Earnings History Data for Nuvalent, Inc. (NUVL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Nuvalent, Inc.
Nuvalent Inc. is a biopharmaceutical company. It focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. The company's program pipeline includes ROS1-positive and ALK-positive NSCLC. Nuvalent Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27-02-2024 | PM | NUVL | Nuvalent | 5,465 | -0.62 | -0.59 | 0.00 | 89.03 | 2.42 (2.79%) |
88.01 | 1.40 (1.62%) |
23.09 - 89.35 | 414,693 | 360,000 | 891 | |||
| 14-11-2023 | PM | NUVL | Nuvalent | 3,242 | -0.59 | -0.59 | 0.00 | Nuvalent GAAP EPS of -$0.59 misses by $0.01 [11/14/2023 6:41 AM] |
58.63 | 1.73 (3.04%) |
0.0 | 0.0 (0.00%) |
23.09 - 65.50 | 570,705 | 480,000 | 0 | ||
| 16-03-2023 | PM | NUVL | Nuvalent | 1,691 | -0.49 | -0.43 | 0.00 | Nuvalent GAAP EPS of -$0.49 [3/16/2023 8:38 AM] |
29.52 | 1.43 (5.09%) |
0.0 | 0.0 (0.00%) |
7.09 - 40.43 | 176,974 | 260,000 | 0 | ||
| 10-08-2022 | PM | 6:30 AM ET (Aug 10) |
NUVL | Nuvalent | 803.00 | -0.38 | -0.43 | 0.00 | Nuvalent GAAP EPS of -$0.38 beats by $0.03 [8/10/2022 8:15 AM] |
17.69 | 2.14 (13.76%) |
16.44 | 0.89 (5.72%) |
7.09 - 40.82 | 185,289 | 130,000 | 1,309 | |
| 12-05-2022 | PM | NUVL | Nuvalent | 446.00 | -0.36 | -0.40 | 0.00 | Nuvalent GAAP EPS of -$0.36 beats by $0.04 [5/12/2022 8:20 AM] |
8.33 | 0.27 (3.35%) |
8.17 | 0.11 (1.36%) |
8.02 - 40.82 | 194,459 | 120,000 | 500 | ||
| 29-03-2022 | PM | 6:30 AM ET (Mar 29) |
NUVL | Nuvalent | 609.00 | -0.36 | -0.32 | 0.00 | Nuvalent GAAP EPS of -$0.36 misses by $0.04 [3/29/2022 7:14 AM] |
13.20 | 0.91 (7.40%) |
12.29 | 0.0 (0.00%) |
11.00 - 40.82 | 101,455 | 360,000 | 1,245 | |
| 10-11-2021 | PM | NUVL | Nuvalent | 1,296 | -0.39 | -0.25 | 0.00 | Nuvalent EPS misses by $0.14 [11/10/2021 6:46 AM] |
26.38 | -0.47 (-1.75%) |
0.0 | 0.0 (0.00%) |
17.00 - 40.82 | 25,520 | 60,000 | 0 | ||